Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease
Abstract Increasing evidence shows that metabolic abnormalities in body fluids are distinguishing features of the pathophysiology of Parkinson’s disease. However, a non-invasive approach has not been established in the earliest or pre-symptomatic phases. Here, we report comprehensive double-cohort a...
Guardado en:
Autores principales: | Shinji Saiki, Taku Hatano, Motoki Fujimaki, Kei-Ichi Ishikawa, Akio Mori, Yutaka Oji, Ayami Okuzumi, Takeshi Fukuhara, Takahiro Koinuma, Yoko Imamichi, Miho Nagumo, Norihiko Furuya, Shuko Nojiri, Taku Amo, Kazuo Yamashiro, Nobutaka Hattori |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/39cf9e83253748d8b72eb80e81610158 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Non-invasive diagnostic tool for Parkinson’s disease by sebum RNA profile with machine learning
por: Yuya Uehara, et al.
Publicado: (2021) -
Diagnosis of atypical myopathy based on organic acid and acylcarnitine profiles and evolution of biomarkers in surviving horses
por: Déborah Mathis, et al.
Publicado: (2021) -
Plasma acylcarnitines and risk of lower-extremity functional impairment in older adults: a nested case–control study
por: Francisco Félix Caballero, et al.
Publicado: (2021) -
Medium & long-chain acylcarnitine’s relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: a metabolomic study
por: Dan-meng Zheng, et al.
Publicado: (2021) -
Fiber-specific white matter alterations in early-stage tremor-dominant Parkinson’s disease
por: Christina Andica, et al.
Publicado: (2021)